Similar articles

• Efficacy and safety of ribosome-component immune modulator for preventing recurrent respiratory infections in socialized children.

  Fiocchi A, Omboni S, Mora R, Macchi A, Nespoli L, Arrigoni S, Guastini L, Castelnuovo P, Graziani D, Marcassa S. Fiocchi A, et al. Allergy Asthma Proc. 2012 Mar-Apr;33(2):197-204. doi: 10.2500/aap.2012.33.3516. Allergy Asthma Proc. 2012. PMID: 22525398 Clinical Trial.
• Ribosome-component immune modulation of respiratory tract infections in adults.

  Olivieri D, Chiesa S, Tzani P, Marino P, Robberto E, Marcassa S. Olivieri D, et al. Allergy Asthma Proc. 2009 Jul-Aug;30 Suppl 1:S13-9. doi: 10.2500/aap.2009.30.3250. Allergy Asthma Proc. 2009. PMID: 19679001
• Ribosome-component immune modulation of respiratory tract infections in children.

  Fiocchi A, Terracciano L, Martelli A, Bernardo L, Calcinai E, Marcassa S. Fiocchi A, et al. Allergy Asthma Proc. 2009 Jul-Aug;30 Suppl 1:S21-31. doi: 10.2500/aap.2009.30.3248. Allergy Asthma Proc. 2009. PMID: 19679002 Review.
• Cost effective analysis of ribosome-component immune modulation.

  Fiocchi A, Olivieri D, Marcassa S, Zava D, Robberto E. Fiocchi A, et al. Allergy Asthma Proc. 2009 Jul-Aug;30 Suppl 1:S37-9. doi: 10.2500/aap.2009.30.3246. Allergy Asthma Proc. 2009. PMID: 19679004 Review.
• Toward prevention or cure for recurrent respiratory papillomatosis.

  Hughes OR. Hughes OR. Laryngoscope. 2012 Dec;122 Suppl 4:S63-4. doi: 10.1002/lary.23805. Laryngoscope. 2012. PMID: 23254606 No abstract available.